Close
Back to SNDX Stock Lookup

Syndax Pharmaceuticals (SNDX) – Momentum Movers

Jul 24, 2023 07:25 AM Syndax Pharmaceuticals (SNDX) Climbs 14% Following Positive Results form Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host Disease
May 17, 2017 10:18 AM Syndax Pharmaceuticals (SNDX) Surges as NSCLS Treatment Advances to Phase 2 Trials

Back to SNDX Stock Lookup